Abstract

The Holden Comprehensive Cancer Center's (HCCC) planning and evaluation activities take place in a variety of settings. These will include annual visits of the External Advisory Committee and annual consultation with program-specific advisors. Other ongoing planning and evaluation activities include implementation of the 3 years strategic plan developed over the past year, and continuation of a focused planning and evaluation effort addressing how we can better develop and support clinical trials. The HCCC will continue with quarterly meetings of the HCCC Internal Advisory Committee, an annual HCCC Leadership Retreat, planning and evaluation during monthly HCCC executive committee meetings, and planning centered around specific research opportunities during the monthly HCCC forum. These are all in addition to the planning and evaluation activities taking place within each program.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA086862-13
Application #
8466207
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
13
Fiscal Year
2013
Total Cost
$40,193
Indirect Cost
$31,212

  Institution

Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242

  Publications

Chiba, Akiko; Raman, Rachna; Thomas, Alexandra et al. (2018) Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer. Clin Breast Cancer 18:144-149
Vikas, Praveen; Borcherding, Nicholas; Zhang, Weizhou (2018) The clinical promise of immunotherapy in triple-negative breast cancer. Cancer Manag Res 10:6823-6833
Alexander, Matthew S; Cullen, Joseph J (2018) Treating pancreatic cancer: more antioxidants more problems? Expert Rev Gastroenterol Hepatol 12:849-851
Lin, Jie; Adjeroh, Donald A; Jiang, Bing-Hua et al. (2018) K2 and K2*: efficient alignment-free sequence similarity measurement based on Kendall statistics. Bioinformatics 34:1682-1689
Koppenhafer, Stacia L; Goss, Kelli L; Terry, William W et al. (2018) mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells. Mol Cancer Ther 17:2676-2688
Lutgendorf, Susan K; Thaker, Premal H; Arevalo, Jesusa M et al. (2018) Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma. Cancer 124:580-586
Krishnamani, Venkatramanan; Peterson, Tabitha A; Piper, Robert C et al. (2018) Informatic Analysis of Sequence Data from Batch Yeast 2-Hybrid Screens. J Vis Exp :
Al-Qurayshi, Zaid; Khadra, Helmi; Chang, Kristi et al. (2018) Risk and survival of patients with medullary thyroid cancer: National perspective. Oral Oncol 83:59-63
Wang, Sophia S; Carrington, Mary; Berndt, Sonja I et al. (2018) HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res 78:4086-4096
Campbell, Hannah; Heidema, Christy; Pilarczyk, Daisy G et al. (2018) SHP-2 is activated in response to force on E-cadherin and dephosphorylates vinculin Y822. J Cell Sci 131:

Showing the most recent 10 out of 1080 publications